Skip to Content

Agilent Technologies Inc A Stock Quote

| Rating as of


Last close prices updated as of Jun 09, 2023, 7:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 115.79
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Investment Style Large Growth
  • Day Range 114.16  –  116.00
  • Year Range 112.52  –  160.27
  • Market Cap 34.2016 Bil
  • Volume / Avg 2.0 Mil /  1.9 Mil
  • Price / Sales 4.89
  • Price / Book 5.92
  • Forward Div Yield 0.78%
  • Trailing Div Yield 0.95%

Morningstar‘s Stock Analysis A

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Life Science Toolmakers Help Ideas Become Drugs While Reinforcing Their Moats

Julie Utterback Senior Equity Analyst

Analyst Note

| Julie Utterback |

Life science toolmakers that enable drug production operate attractive businesses for two major reasons that investors often find compelling. First, regulation of the drug manufacturing process creates highly durable switching costs for end users and long potential revenue streams for life science toolmakers. Second, life science firms often benefit from broad exposure to biopharmaceutical growth without taking on much product-specific risk.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics A

Company Profile A

Business Description

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.

5301 Stevens Creek Boulevard
Santa Clara, CA, 95051
Industry Diagnostics & Research
Employees 18,400

Related Articles A

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of A’s competitive advantage.

Agilent Technologies Inc


Danaher Corp


Thermo Fisher Scientific Inc


Waters Corp

+$1.10 (0.96%) −$0.04 (0.02%) +$2.93 (0.57%) −$0.68 (0.27%)
Market Cap
34.20 Bil173.68 Bil199.87 Bil14.72 Bil
Diagnostics & Research Diagnostics & Research Diagnostics & Research Diagnostics & Research

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Agilent Technologies Inc Stock

Yes. A has a forward dividend yield of 0.78%. See A’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

A’s market cap is 34.20 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

A’s stock style is Large Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

A’s price/sales is 4.89.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

A’s price/forward earnings is 25.50.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

A’s price/book is 5.91.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See A’s valuation ratios compared to the Market Index.

A’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare A’s historical performance against its industry peers and the overall market.